ADTX: Aditxt, Inc. Stock

by  •  • Comments Off on ADTX: Aditxt, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1.64
Enterprise Value ($M) 3.45
Book Value ($M) 15.76
Book Value / Share 13.73
Price / Book 0.10
NCAV ($M) -14.24
NCAV / Share -11.79
Price / NCAV -0.12

Profitability (mra)
Return on Invested Capital (ROIC) -1.28
Return on Assets (ROA) -0.91
Return on Equity (ROE) -2.60

Liquidity (mrq)
Quick Ratio 0.08
Current Ratio 0.08

Balance Sheet (mrq) ($M)
Current Assets 1.22
Assets 31.22
Liabilities 15.46
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.13
Operating Income -27.86
Net Income -34.45

Cash Flow Statement (mra) ($M)
Cash From Operations -16.76
Cash from Investing -5.00
Cash from Financing 22.50

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT P
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For fiscal year ended: December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION
2024-11-18 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPO
2024-08-19 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PU

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-02 43,990 134,713 32.65
2025-05-30 32,103 210,940 15.22
2025-05-29 14,797 85,792 17.25
2025-05-28 7,202 22,889 31.46

(click for more detail)

Similar Companies
ACHV – Achieve Life Sciences, Inc. ACXP – Acurx Pharmaceuticals, Inc.
ADIL – Adial Pharmaceuticals, Inc. ADVM – Adverum Biotechnologies, Inc.
AGEN – Agenus Inc.


Financial data and stock pages provided by
Fintel.io